MCI Case Study
This executive summary and case study was written by four student fellows of the Lipman Family Prize with faculty oversight to highlight MCI’s impact and transferability across various contexts and locations, as well as its scaling potential and future plans.
- Using sophisticated cohort studies and randomized controlled trials in partnership with universities such as the Harvard School of Public Health and UCSF, MCI has demonstrated the effectiveness of the microclinic model through statistically significant improvements in participant health indicators across various chronic diseases.
- In Jordan and Kentucky, MCI has tracked participant improvements in weight, BMI, and HbA1c, as well as through other qualitative indicators related to diabetes, heart disease, and obesity. Moreover, MCI found evidence of social contagion as those who had a higher BMI than the microclinic average lost more weight than those who had a similar BMI as compared to their microclinic average.
- In Kenya, MCI has successfully launched a groundbreaking microclinic pilot program for HIV/AIDS in partnership with its local partner, Organic Health Response. This ongoing Kenya study tracks participant progress through indicators such as medication adherence, CD4 count, opportunistic infections, and body mass index.